Picornavirus 2B, a non-structural protein required for effective viral replication, has been implicated in cell membrane permeabilization during the late phases of infection.
Summary
Picornavirus 2B, a non-structural protein required for effective viral replication, has been implicated in cell membrane permeabilization during the late phases of infection.
Here, we have approached the molecular mechanism of this process by assessing the pore-forming activity of an overlapping peptide library that spanned the complete 2B sequence. At non-cytopathic concentrations, only the P3 peptide, spanning 2B residues 35-55, effectively assembled hydrophilic pores that allowed diffusion of low-molecular weight solutes across the cell plasma membrane (IC 50 ≈ 4x10 -7 M) and boundary liposome bilayers (starting at peptide-to-lipid mole ratios > 1:10 4 ). Circular dichroism data were consistent with its capacity to fold as a helix in a membrane-like environment.
Furthermore, addition of this peptide to a sealed plasma-membrane model, consisting of retinal rod outer segments patch-clamped in a whole-cell configuration, induced within seconds ion channel activity at concentrations as low as 10 -8 M. Thus, we have established a "one-helix" 2B version that possesses the intrinsic pore-forming activity required to directly and effectively permeabilize the cell plasma membrane. We conclude that 2B viroporin can be classified as a genuine pore-forming toxin of viral origin, which is intracellularly produced at certain times post-infection.
Introduction:
Induction of non-selective pores in membranes constitutes an ancestral form of defense-offense adopted by a wide variety of organisms 1; 2; 3; 4; 5 . Cytolytic poreforming proteins and peptides targeting the plasma membrane of animal cells are produced by bacteria, vertebrates (as components of their immune systems), sea anemones, amoeba and fungi, and are also present in the venom of arthropods and snakes 1; 2; 4; 6; 7 . Although these cytotoxic polypeptides share little sequence homology, they almost invariably assemble into permeating structures that allow passive flux of ions and other solutes across membranes 1; 2; 8; 9
. To date, no functional homologs of viral origin similar to these ancient weapons have been discovered, even though enhanced membrane permeability is typically observed during infection of susceptible cells by most animal viruses 10 .
Membrane permeabilization, together with morphological alterations induced by virus replication such as nuclear modifications, disruption of the cytoskeletal network 11; 12; 13 and the appearance of cytoplasmic membrane vesicles 14; 15 have been collectively referred to as the cytopathic effect. In the case of naked viruses, intracellular accumulation of viral particles and/or massive expression of viral products have often been causally linked to non-specific membrane damage processes that are postulated to enhance permeability, cell lysis and ultimately release of new progeny 16; 17 . An alternative possibility in which specific, virally encoded products sustain this phenomenon was predicted many years ago 18; 19; 20 . The results of a variety of experiments pointed to the involvement of certain pore-like structures in the process.
Membrane leakiness observed after the mid-phase of picornavirus infection was nonspecific for ions and small molecules (e.g., nucleotides, sugars, amino acids and inhibitors with a MW below 1,500 daltons), but not for macromolecules 10 . Moreover, individual expression of distinct viral genes was subsequently found to reproduce this process in several cell systems 21; 22; 23; 24; 25; 26; 27; 28; 29 . The name "viroporin" was proposed on observing that several virus proteins with potential permeabilizing activity might share common characteristics 26; 30; 31; 32 .
The picornavirus 2B viroporin has received much attention for several reasons.
First, picornaviruses provide an example of enhanced membrane permeability during the latter phases of the virus cycle 19; 33; 34 . Second, individual expression of 2B induces plasma membrane permeabilization in mammalian cells, the effect being even stronger for 2BC precursor 21; 22; 23; 28; 32; 35; 36 . Third, the 2B sequence bears two potential transmembrane domains (TMDs), which, although of modest hydrophobicity, might allow partitioning into membranes and oligomeric pore assembly 27; 29; 32; 37; 38 . Indeed, evidence for 2B oligomerization at membrane surfaces has been obtained in culture cells and liposomes 35; 37 . Finally, a soluble and purified 2B fused to maltose binding protein (MBP-2B) induces liposome permeabilization to low-molecular weight solutes 37 . Taken together, this evidence suggests a mechanism of membrane permeabilization similar to that of certain cytolytic toxins.
In the present work, we provide compelling evidence for the intrinsic capacity of poliovirus (PV) 2B viroporin to form stable, size-limited, non-selective pores at the cell plasma membrane. We have identified within a library that spanned the complete 2B sequence a helical peptide that displayed 2B-like permeabilizing activity when added to cultured cells in the nM range concentration. Plasma membrane permeabilization was limited to low molecular-weight solutes, operated at 4 and 37 ºC, and was inhibited by the external addition of impermeable streptavidin when biotinylated peptides were used.
Direct and irreversible pore-formation on plasma membrane under physiological conditions was finally confirmed by a series of electrophysiological measurements, which revealed ion channel activity developing within seconds after applying directly the peptide onto a cell recorded in whole-cell configuration. We conclude that 2B
viroporin constitutes a new class of pore-forming protein that functions during infection as an intracellularly delivered toxin. Accordingly, we speculate that viroporin lytic domains might represent new potential leads for the development of bioactive peptides, and/or serve as targets for the development of antiviral compounds.
Results:

Mapping cell permeabilizing activity with a 2B peptide library
Based on the fact that synthetic peptides representing a single helix may retain the capacity of the parental polypeptide sequences to assemble ion channels and pores in membranes 39; 40; 41; 42 , we synthesized a library of soluble peptides (Table 1) , and assayed them for their capacity to permeabilize cultured cells (Figure 1 ). Moreover, TMD mimics designed as soluble species have been used for the analysis of the specific in-membrane molecular recognition sustaining channel and surface receptor function 43; 44; 45; 46 . Even if P3 bears an amphipathic character at its N-terminus, we found empirically that this sequence required at least 3 extra Lys residues to become a watersoluble species (not shown). Thus, both P3 and P5 peptides spanning 2B most hydrophobic regions ( Figure 1A ) included additional Lys-residues (Table 1) to yield the hydrophobicity of a range of previously described aqueous-soluble TMD sequences 44; 47 .
The data shown in Figure 1B compare the abilities of the peptides to permeabilize cell monolayers. Single expression of 2B from an alphavirus replicon induces entry of the translation inhibitor hygromycin B (HB) into BHK-21 cells, a process that can be monitored as a reduction in protein synthesis by the culture (righthand panel). Similarly, addition of P3 to the culture medium permeabilized cells to HB efficiently, whereas the rest of the peptide-library had virtually no effect, as was the case for untreated controls (left-hand panel). This trend in the cell monolayer permeabilization process induced by 2B peptides was observed even with the highest concentration tested (20 M, not shown).
In our assays, the peptides partitioned from the aqueous medium into the membranes of culture cells. In order to estimate the capacity of each peptide to insert into the cell plasma membrane under these experimental conditions, their insertion into lipid monolayers was measured (Table 1) . Estimation of the critical pressure for insertion (i.e., the surface pressure at which the sequences were excluded from the lipid monolayer,  c ) indicated that the P3 capacity for insertion correlated with its permeabilizing activity. P5, which was unable to effectively permeabilize cells, also had a high capacity for insertion into membranes, while P4, comprising the sequence that connects P3 and P5, was clearly unable to penetrate at the surface pressures present in unstressed natural membranes ( c ≥ 30 mN/m). ways. P3 exhibited a certain degree of structuring in solution whereas P4 and P5 were largely unstructured. This finding suggests that P3 might form oligomers under these conditions. The observation that P3 CD spectra measured at 10 and 100 M concentration were similar, together with the fact that C-terminal Trp fluorescence increased linearly with increasing concentrations would be consistent with the existence of a predominant one-sized P3 oligomer (not shown).
P3 also adopted a highly -helical conformation in solutions containing sodium dodecyl sulfate (SDS), consistent with its further structuring in the membranemimicking detergent micelles 44; 47 . By comparison, P4 remained largely unstructured, while P5 helicity was modest in the presence of micelles. All the additional 2B peptides Overall, these observations suggest the presence in cell plasma and vesicle
membranes of stable open aqueous channels with common characteristics (sequence specificity, solute size limit and stability). The fact that P3-induced permeabilization also occurred at 4ºC, a temperature at which receptor-mediated endocytosis is inhibited, reinforced this notion ( Figure 5 ). Moreover, cell membranes remained permeabilized after removal of P3 from the medium and when cell cultures were allowed to return to normal temperature conditions (37ºC).
P3 permeabilizing activity is inhibited at plasma membrane
The effects described in the previous Moreover, this inhibitory effect was also observed when P3 was pre-incubated with cells to allow its insertion into membrane (Protocol "b").
Direct inhibition of biotinylated P3 by streptavidin was confirmed in pure lipid vesicles using similar protocols ( Figure 6C ). Streptavidin addition (indicated by the arrows) to the vesicles prior to peptide could inhibit the release of internal aqueous contents induced by P3 (panel a). The ongoing permeabilization process could be also arrested by adding streptavidin after the peptide (panel b). Thus, the fact that recognition of membrane-bound P3 by non-permeant streptavidin inhibited permeabilization is consistent with the idea that P3 established permeating pores at the surface of cells and liposomes. We surmise that the most likely explanation for the inactive streptavidin-peptide conjugate could be that binding of the peptide to streptavidin might prevent the creation of an oligomer and hence inhibit pore formation.
Fast and irreversible formation of P3 ion channels after addition to a natural plasma membrane
Electrophysiological measurements finally confirmed that P3-induced cell permeabilization was occurring through a direct pore-forming mechanism and not indirectly by affecting other cellular components ( Figure 7 ). Kinetics of P3 ion channel formation was studied in the isolated retinal rod outer segments (OS) of amphibia (see Figure 7A ). This system was selected because patch-clamped OS allow the detection of currents on a natural cell plasma membrane, i.e., under physiological conditions that preserve its lipid asymmetry and composition. . If the OS are illuminated, the light sensitive channels close; furthermore, the exchanger can be blocked by removing just one of the ion species that it transports (Na + , Ca 2+ or K + ) from both sides of the membrane. The exchanger current can be also reduced to negligible amplitudes by minimizing the electrochemical gradients of the transported ions. Under these conditions, the OS membrane resistance recorded in whole cells ( Figure 7A ) typically exceeded 1 G, allowing the detection of developing currents produced by the added peptides with high resolution (1 pA for a bandwidth of at least 1 kHz, Figure 7B ).
The kinetics of ion channel formation after P3 and P5 addition was therefore tested as follows ( Figures 7A and B) . With the isolated OS continuously held at a fixed voltage (V h ; range: -60 -+60 mV), the membrane resistance (R m ) was measured before peptide perfusion. The peptide was then quickly applied (<100 ms) using a fast perfusion system ( Figure 7A ) and R m was measured again once the current had stabilized. The OS were finally returned to the control solution (without the peptide) to assess a possible recovery of the current. No significant changes in current level or R m were induced by continuous perfusion of P5 (5 out of 5 OS) for up to 100 seconds at concentrations up to 1 M ( Figure 7B , gray traces). In these experiments, V h was varied between -60 and +60 mV to rule out the possibility that the lack of ion channel formation was due to an inappropriate V h . For instance, many peptides such as peptaibols permeabilize the membrane to ions when the intracellular side is held at a negative voltage 53 . In contrast, P3 was able to significantly permeabilize the OS plasma membrane to ions when applied at concentrations as low as 10 nM (Table 2 ). Perfusion at 100 nM for a few tens of seconds (typically ~40 s) permeabilized the OS plasma membrane to the extent that R m decreased by three orders of magnitude and became comparable to the access resistance in approximately one minute (R a , Figure 7B , black traces; see also Table 2 ).
The increase in plasma membrane permeability to ions induced by the peptide can be quantitatively described in this system by kinetic parameters such as the "activation delay", defined as the time between peptide application and when a change of the current baseline larger than 3 times its average value occurs (indicated by the arrow in the inset of Figure 7B ), and the current amplitude at steady-state. In the case of P3, at a fixed voltage (V h = -20 mV), the activation delay and the current amplitude displayed inverse and direct relationships, respectively, with P3 concentration (Table 2 ).
Both parameters were independent of V h over the range -60 to +60 mV. Accordingly, the current to voltage relationship, measured once the current was stable with a voltage ramp from -60 to +60 mV ( Figure 7C ), was linear and similar to that predicted by Ohm's law with a resistance approximately equal to R m (22 M in the example of Figure 7C ).
In order to evaluate P3 potency as an ion-channel former, its activity was compared to that of the standard -helical pore-forming peptide alamethicin 54 , measured under exactly the same experimental conditions ( Figure 7D ). Alamethicin addition induces ion channels in membranes through the self-association into rings of transmembrane helices 5; 55; 56 , which are very efficient at increasing conductance of artificial lipid bilayers 57 . Thus, the activation delay times for 1 M alamethicin assayed in the OS system was in the range of 2 seconds, a value lying in between those obtained for 0.1 and 1 M of P3, whereas the current amplitude at steady-state was roughly one third of that produced by 0.1 M of P3. Thus, in electrophysiological measurements of natural OS plasma membranes, P3 would be at least 10 times more potent than alamethicin as an ion-channel former. . This mutant was intracellularly synthesized by the translational machinery and subsequently transported to the site of permeabilization, while peptides in the present study were supplied exogenously and, therefore, had direct access to the plasma membrane. Only P3 was endowed with the capacity of permeabilizing the plasma membrane (panel B in Figure 1 ). Thus, from the combination of both approaches we propose now that deletion of the first 30 residues of 2B may affect proper in-membrane folding and/or its trafficking along the vesicular system. Moreover, P1, P2 and P6 peptides became structured to some degree in SDS micelles and inserted into lipid monolayers at lateral pressures slightly above 30 mN/m (Table 1 ), suggesting that the 2B sequences represented by these peptides might also play supportive functional roles in permeabilization, for instance as structural partners that ensure membrane insertion or regulate the pore-opening process.
The potency of the P3 sequence (active in the nM range) and the observation that the process is efficient in the absence of active transport (Figures 3 and 5 ) support the formation of channel-forming pores directly at the plasma membrane as the likely mechanism for P3-induced cell permeabilization. Furthermore, these pores are discrete and stable structures (i.e., they remain opened once they assemble and show a limiting size for the permeating solute) both in cells and lipid vesicles (Figures 3 and 4) . In support of this view, biotinylated-P3 itself localizes at the plasma membrane and its action might be inhibited by external addition of streptavidin ( Figure 6A ) which, together with the fact that the peptide pores could be inhibited also in pure lipid vesicles ( Figure 6B ), is again indicative that cell permeabilization is mediated by P3 pores established directly in the lipid phase of the plasma membrane.
In the case of antimicrobial peptides it has been established a correlation between biological activity and binding and disrupting of model membranes 58 . In this regard, P3's behavior, namely, structuring in solution and capacity to permeabilize animal cell membranes and zwitterionic vesicles, parallels that of certain natural membranolytic peptides, such as cecropin-like human LL-37 59; 60 , and synthetic species covalently linked to pre-form bundles 61 . .
The P3 pore hypothesis received conclusive support from electrophysiological measurements carried out on the frog OS model (Figure 7 ). This approach allowed the ion channel activity of P3 to be measured in a natural plasma membrane, i.e., under experimental conditions comparable to those in cell permeability assays. The measured activation delay times (arrow in the inset of Figure 7B ) were in the order of few seconds, supporting that the assembly of P3 pores occurs directly at the plasma The model in Figure 8 suggests possible structural correlations between P3 and 2B pores formed in the cell plasma membrane. Overall hydrophobic P3 sequence may attain in the external solution a periodic structure which exposes positively charged Lys residues in one of its sides (a), and subsequently self-assemble to shield the hydrophobic surfaces (b). In the resulting oligomeric P3 form (c) the amino-terminal end would be hydrophilic (pale grey surface), while the carboxy terminus would be overall hydrophobic (black). This degree of amphipathicity allows both, enough solubility and potential for association with the uncharged external plasma membrane monolayer through hydrophobic interactions. In the membrane-inserted state the charged residues reorient towards the lumen of an aqueous channel (d). In the 2BC
precursor there exists the possibility of shielding hydrophobic sequences into the globular structure (e). Electrostatic interactions are probably important for its association with cell membrane monolayers topologically equivalent to the negatively charged internal monolayer of the plasma membrane. Several monomers are probably recruited at the membrane surface to establish an aqueous channel (f). In the latter oligomeric structure P3-P5 sequences would combine in each monomer to form a hairpin "-loop-" motif so that both the N-and the C-terminal ends of the polypeptide remain at the same side of the membrane. In such a model the amphipathic P3 helix would serve to establish the interface between the lumen of the aqueous pore and the hydrophobic milieu of the membrane, adopting a topology reminiscent to that in the pore formed by the synthetic peptide (compare f and d).
However we caution that at this point we cannot rule out the existence of P3
topologies, different to membrane-spanning helices, which might be also lytic. In addition, the channel-forming model presented in Figure 8 does not discriminate between only-protein channels (barrel stave pore 40; 62 ) or pores that are also participated by membrane phospholipids (toroidal pores 56 62; 63 . Thus, it may be that similar pore-forming motifs were co-opted during the course of evolution of certain viruses in order to induce cell death under conditions of cytopathic infection.
The precise function of 2B during the PV infectious cycle has yet to be elucidated. Overexpressed 2B species accumulate in the endoplasmic reticulum and the Golgi apparatus, interfere with transport of glycoproteins to the cell surface, induce internal membrane restructuring and increase the levels of cytoplasmic calcium and other ions 21; 22; 23; 28; 35; 71 . Researchers have proposed that many if not all of these effects are a consequence of the membrane permeabilizing capacity of these species 36 .
Thus, 2B-generated solute imbalance across cellular endomembranes might compromise organelle function, thereby creating suitable conditions for productive viral replication. Our studies support this possibility, while contributing to the knowledge of the 2B non-selective pore architecture.
Concluding remarks
Non-structural enterovirus 2B has been postulated as an example of the viroporin family. These virally encoded proteins are postulated to compromise cell membrane permeability barriers 30 . The existence of a 2B domain optimized for membrane-porating function would support the proposal that viroporins represent a new class of intracellular toxins. In addition, 2B-derived P3 encompasses a one-helix miniprotein with a high pore-forming potency. Hence, its activity in lipid vesicles could be used as a surrogate measure in screening for compounds that abrogate this activity. It was previously postulated that interfering with 2B viroporin activity might block viral replication as well as virus release 28; 35 . The present study provides the necessary framework to verify that hypothesis. A growing number of viruses that encode viroporin sequences have been described 30 . It will be of great interest to explore viroporins as a source of peptide-based structures to develop new bioactive compounds.
Materials and Methods
Materials
The poliovirus 2B-derived P1-P6 peptides displayed in Table 1 were produced by solidphase synthesis using Fmoc chemistry as C-terminal carboxamides and purified by HPLC. Phosphatidylcholine (PC) and N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) phosphatidylethanolamine (N-NBD-PE) were purchased from Avanti Polar Lipids 
Lipid monolayer assays
For the monolayer penetration assays, surface pressure was determined in a fixed-area circular trough (Trough S system, Kibron, Helsinki) measuring 2 cm in diameter and with a volume of 1 ml. The aqueous phase consisted of 1 ml of 5 mM Hepes, 100 mM NaCl (pH 7.4). Lipids, dissolved in chloroform, were spread over the surface and the desired initial surface pressure ( 0 ) was attained by changing the amount of lipid applied to the air-water interface. Peptides were injected into the subphase with a Hamilton microsyringe. At the concentrations used, the peptides alone induced a negligible increase in surface pressure at the air-water interface.
Lipid vesicle assays
Large unilamellar vesicles (LUV) of phosphatidylcholine were prepared according to the extrusion method in 5 mM Hepes, 100 mM NaCl (pH 7.4). Vesicle permeabilization was assayed by monitoring the release to the medium of encapsulated fluorescent ANTS (ANTS/DPX assay 73 ) or FITC-dextran probes, as previously described 74 . In a complementary assay, permeabilization was also assessed by monitoring the entry of dithionite into vesicles according to the method described by McIntyre and Sleight
75
, with the modifications introduced by Agirre et al. 37 .
Ion Channel activity
Rod outer segments (OS) were mechanically isolated from the retina of dark adapted Rana esculenta individuals as described by Rispoli et al. 51 . OS were recorded using the whole-cell configuration of the patch-clamp technique under visual control (Fig. 7A) mOsm/Kg, buffered to pH=7.6; all chemicals were purchased from Sigma Chemical Co.). The peak amplitude of the current transient elicited by -5 mV pulses (delivered at 10 Hz) was used to measure access resistance (R a ), whereas the current amplitude elicited by a -10 mV pulse during cell-attached and whole-cell recording was used to measure seal resistance and membrane resistance (R m ), respectively.
After obtaining the whole cell recording, the cell was aligned in front of a multibarreled perfusion pipette that could be moved on a horizontal plane ( ). See text for details. 
